1Scott MG,Vreugdenhil AC,Buurman WA,et al.Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein[].J Immunol.2000
2de-Haas CJ,van-der-Zee R,Benaissa-Trouw B,et al.Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS[].Infection and Immunity.1999
3de-Haas CJ,van-Leeuwen EM,van-Bommel T,et al.Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharidemediated classical pathway complement activation[].Infection and Immunity.2000
4Krensky AM.Granulysin: a novel antimicrobial peptide of cytolytic T lymphocytes and natural killer cells[].Biochemical Pharmacology.2000
5Weinrauch Y,Katz SS,Munford RS,et al.Deacylation of purified lipopolysaccharides by cellular and extracellular components of a sterile rabbit peritoneal inflammatory exudate[].Infection and Immunity.1999
6Turner J,Cho Y,Dinh NN,et al.Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils[].Antimicrobial Agents and Chemotherapy.1998
7Beamer LJ,Carroll SF,Eisenberg D.The three-dimensional structure of human bactericidal/permeability-increasing protein: implications for understanding protein-lipopolysaccharide interactions[].Biochemical Pharmacology.1999
8Calafat J,Janssen H,Knol EF,et al.The bactericidal/permeability-increasing protein (BPI) is membrane-associated in azurophil granules of human neutrophils, and relocation occurs upon cellular activation[].Acta Pathologica Microbiologica et Immunologica Scandinavica.2000
9Kitchens RL,Wolfbauer G,Albers JJ,et al.Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface[].Journal of Biological Chemistry.1999
10de-Haas CJ,Poppelier MJ,van-Kessel KP,et al.Serum amyloid P component prevents high-density lipoprotein-mediated neutralization of lipopolysaccharide[].Infection and Immunity.2000
